drugset / Trial / NCT01956110

Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 1

NCT01956110 ↗

Phase 3 Completed 1329 enrolled Ferring Pharmaceuticals
RandomizedParallel-groupSingle-blindTreatment

Summary

This trial investigates the effects of FE 999049 compared to GONAL-F.

Timeline

Start
2013-10
Primary completion
2015-05
Completion
2017-01-03

Outcome

Met primary endpoint

paper Ongoing pregnancy (30.7% vs. 31.6%; difference -0.9% [95% confidence interval (CI) -5.9% to 4.1%]) PMID 27912901 ↗

paper ongoing implantation (35.2% vs. 35.8%; -0.6% [95% CI -6.1% to 4.8%]) PMID 27912901 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Follitropin delta Protein / enzyme biologic 0.1 ug/kg —
Subject Follitropin delta Protein / enzyme biologic 0.19 ug/kg —
Subject Follitropin delta Protein / enzyme biologic 12 ug —
Comparator Gonal-f Protein / enzyme biologic 150 iu —

Indications